Free Trial

Genpact Limited (NYSE:G) Shares Sold by First Trust Advisors LP

Genpact logo with Business Services background

First Trust Advisors LP trimmed its stake in Genpact Limited (NYSE:G - Free Report) by 1.2% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 3,804,297 shares of the business services provider's stock after selling 47,017 shares during the period. First Trust Advisors LP owned about 2.16% of Genpact worth $163,394,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in G. Atlas Capital Advisors Inc. raised its position in shares of Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after acquiring an additional 216 shares in the last quarter. CIBC Asset Management Inc raised its stake in Genpact by 5.5% during the 4th quarter. CIBC Asset Management Inc now owns 5,692 shares of the business services provider's stock worth $244,000 after acquiring an additional 297 shares in the last quarter. Tealwood Asset Management Inc. lifted its position in Genpact by 1.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 24,658 shares of the business services provider's stock valued at $1,059,000 after acquiring an additional 339 shares during the last quarter. UMB Bank n.a. increased its position in shares of Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after purchasing an additional 433 shares in the last quarter. Finally, OneAscent Wealth Management LLC boosted its position in shares of Genpact by 5.5% in the 4th quarter. OneAscent Wealth Management LLC now owns 8,380 shares of the business services provider's stock valued at $360,000 after purchasing an additional 439 shares during the period. Institutional investors and hedge funds own 96.03% of the company's stock.

Genpact Price Performance

Shares of G traded up $0.28 on Thursday, reaching $47.83. The stock had a trading volume of 1,248,598 shares, compared to its average volume of 1,479,718. Genpact Limited has a twelve month low of $30.38 and a twelve month high of $56.76. The firm has a market capitalization of $8.40 billion, a PE ratio of 16.84, a PEG ratio of 1.84 and a beta of 1.06. The firm has a 50-day moving average of $50.04 and a 200 day moving average of $46.20. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. Sell-side analysts expect that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were issued a dividend of $0.17 per share. The ex-dividend date was Tuesday, March 11th. This is an increase from Genpact's previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.42%. Genpact's payout ratio is 23.94%.

Insider Activity

In related news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 2.80% of the company's stock.

Wall Street Analyst Weigh In

G has been the topic of several recent research reports. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Mizuho increased their price target on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. TD Cowen raised Genpact from a "hold" rating to a "buy" rating and lifted their price objective for the company from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Needham & Company LLC increased their target price on Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Five investment analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, Genpact presently has a consensus rating of "Hold" and an average target price of $50.38.

View Our Latest Report on G

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines